Why should you attend ATS 2017?
If you are a respiratory medicine practitioner, scientist, clinical researcher, or related health care professional, the ATS International Conference is a can’t-miss event! Here’s why:
History, Size, and Scope. ATS 2017 will mark the 113th year of the conference, making it the longest running, large-scale conference in the world offering groundbreaking research in pulmonary, critical care, and sleep medicine. This year, we’re bringing the conference back to where it began in 1905 - Washington, DC!
Networking and Engagement. Networking opportunities are a vital component of your conference experience, and can help lay the groundwork for future professional collaborations and opportunities. Last year, more than 16,000 attendees joined us for the ATS International Conference. Clinicians, researchers, and related health care professionals from more than 90 countries will come together for ATS 2017 to connect face to face with world-renowned leaders and colleagues across disciplines on the latest scientific research and findings in medical science and thoracic medicine.
Access to Cutting-Edge Science and Research. Through approximately 6,700 abstracts and case reports, and 500 sessions, more than 800 presenters will share with you the very latest research and scientific findings. You’ll hear from world-renowned clinicians and scientists who will reflect on milestones in the pulmonary, critical care, and sleep fields, as well as discuss how advances in science will impact respiratory medicine.
The Latest Technology and Innovation. More than 200 exhibitors will be on-site to offer you a hands-on opportunity to explore new technologies, services, and innovative products. The ATS International Conference keeps you current on the latest tools available - it’s the site of numerous new product launches, so you’ll get a first look at new offerings in areas such as pharmacotherapy, electronic health record technology, spirometer testing, digital data acquisition, and much more.
Key Findings of Landmark Studies are Announced Here First. The ATS International Conference serves as a platform for researchers to release significant findings and scientific discoveries. ATS 2017 will continue this tradition of bringing you the latest clinical and scientific advances, and will serve as a forum for those who shape the future of medicine.
Who Should Attend
The ATS International Conference is the home of pulmonary, critical care, and sleep professionals, from those in the earliest stages of their careers to those whose research or strides in clinical care has gained them international recognition. Each year, nearly 14,000 of these professionals choose to attend, present, and learn about the latest advances, meet with colleagues from around the world, and strike new collaborations. It is truly where today’s science meets tomorrow’s care.
The International Conference is also multidisciplinary. Clinicians and researchers in many other fields attend the conference, thereby enriching conversations that lead to insights that ultimately improve patient care. Among the many other specialties represented in sessions at the International Conference are:
Equally important, the ATS International Conference gathers the entire health care team in one place to share ideas across these medical and scientific disciplines. It is the ideal place for nurses, respiratory therapists, and hospitalists to discuss their experiences, challenges, and research so that all can learn about the latest advances in understanding pulmonary disease, critical illness, and sleep disorders.
And of course, the International Conference is truly international: 40 percent of attendees arrive from laboratories and patient care centers beyond the United States.
We invite you to participate in the ATS 2017 International Conference Exhibition in Washington DC. This is the preeminent conference on pulmonary, critical care, and sleep medicine in the United States. The ATS appreciates the significant contributions made by exhibiting and sponsoring companies. As one of the largest professionally attended pulmonary meetings in the United States and the first healthcare meeting to have an independent third-party audit of our registration data performed, our goal is to make this conference an increasingly productive and profitable experience for you.
We are committed to providing an environment that fosters discussion of your product or service to the over 12,000 pulmonary, critical care, and sleep researchers and clinicians who will attend ATS 2017. We strive to facilitate beneficial interactions between attendees and exhibitors, as well as help you achieve the greatest ROI for your company.
Exhibit space sales are already underway!
Founded in 1905 as the American Sanatorium Association to prevent, control, and treat tuberculosis; renamed the American Trudeau Society in 1938 and the American Thoracic Society in 1960. Originally the medical section of the American Lung Association, the Society became independently incorporated in 2000 as a 501 (c) (3) organization.
The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders. Founded in 1905 to combat TB, the ATS has grown to tackle asthma, COPD, lung cancer, sepsis, acute respiratory distress, and sleep apnea, among other diseases.